Stoke Therapeutics, Inc. Shares Outstanding (Cover Page)
Stoke Therapeutics, Inc. (STOK) had Shares Outstanding (Cover Page) of 64.53 million shares as of 2026-07-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-03
- 2026-07-30: Entity Common Stock, Shares Outstanding 64.53M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 62.28M shares.
- 2026-02-28: Entity Common Stock, Shares Outstanding 59.15M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 57.12M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 64.53M shares 10-Q · filed 2026-08-03 |
| 2026-04-30 | 62.28M shares 10-Q · filed 2026-05-07 |
| 2026-02-28 | 59.15M shares 10-K · filed 2026-03-16 |
| 2025-10-31 | 57.12M shares 10-Q · filed 2025-11-04 |
| 2025-07-31 | 54.80M shares 10-Q · filed 2025-08-12 |
| 2025-04-30 | 54.60M shares 10-Q · filed 2025-05-13 |
| 2025-02-28 | 54.08M shares 10-K · filed 2025-03-18 |
| 2024-10-31 | 52.97M shares 10-Q · filed 2024-11-05 |
| 2024-07-31 | 52.65M shares 10-Q · filed 2024-08-07 |
| 2024-04-29 | 52.12M shares 10-Q · filed 2024-05-06 |
| 2024-03-15 | 46.30M shares 10-K · filed 2024-03-25 |
| 2023-10-30 | 44.65M shares 10-Q · filed 2023-11-07 |
| 2023-07-31 | 44.26M shares 10-Q · filed 2023-08-07 |
| 2023-04-26 | 44.19M shares 10-Q · filed 2023-05-04 |
| 2023-02-23 | 44.15M shares 10-K · filed 2023-03-06 |
| 2022-10-31 | 39.43M shares 10-Q · filed 2022-11-14 |
| 2022-07-31 | 39.42M shares 10-Q · filed 2022-08-08 |
| 2022-05-02 | 39.19M shares 10-Q · filed 2022-05-10 |
| 2022-03-01 | 37.36M shares 10-K · filed 2022-03-10 |
| 2021-11-01 | 36.79M shares 10-Q · filed 2021-11-08 |
| 2021-08-03 | 36.75M shares 10-Q · filed 2021-08-10 |
| 2021-05-03 | 36.71M shares 10-Q · filed 2021-05-10 |
| 2021-03-01 | 36.66M shares 10-K · filed 2021-03-09 |
| 2020-11-05 | 33.47M shares 10-Q · filed 2020-11-12 |
| 2020-08-04 | 33.24M shares 10-Q · filed 2020-08-10 |
| 2020-05-08 | 32.97M shares 10-Q · filed 2020-05-15 |
| 2020-03-16 | 32.94M shares 10-K · filed 2020-03-23 |
| 2019-11-12 | 32.73M shares 10-Q · filed 2019-11-12 |
| 2019-08-14 | 32.72M shares 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |